CTSA CCOS Center’s Post

Struggling with the terms in scientific papers? Check out our new infographic that helps break down key data analysis and statistics terms to help you understand and engage with scientific research more effectively. Thanks to Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) for developing plain language clinical research glossary and collaborating with us. Please find the full glossary here: #leighsyndrome #mitochondrialdisease

We are proud to share important research authored by AJMA members titled: "Social Media, Survey, and Medical Literature Data Reveal Escalating Antisemitism Within the United States Healthcare Community." 🔍 Key Findings: Publications and social media posts addressing antisemitism have increased >5x, while antisemitic stereotypes in posts rose by 2-4x. 75.4% of Jewish medical students and professionals reported experiencing antisemitism. This study highlights a concerning rise in antisemitism within the healthcare community, particularly after the events of October 7, 2023. 📰 Read the full article below. https://lnkd.in/gXPDYRdw #AJMAResearch #HealthcareEquity #EndAntisemitism #MedicalCommunity #SocialJustice

Moran scientist Frans Vinberg, PhD, is part of a project bringing together more than 40 scientists, doctors, and industry experts hand-picked from around the country to make sight-restoring whole eye transplants a reality. Advanced Research Projects Agency for Health (ARPA-H) https://lnkd.in/gdj4xB72

This work will be a part of large consortium effort led by Dr. Goldberg from Stanford. For the past 5 years, we have worked together with Utah Lions Eye Bank and DonorConnect to establish an infrastructure for the use of organ donor human eyes that remain light-responsive at scale. We will help to establish conditions for restoration and preservation of light signaling in the human central and peripheral retina in the donated eyes until their transplantation. Thankful for the John A. Moran Eye Center for providing an excellent environment for this research and of course the donors and their families without whom none of this would be possible.

The Nearsightedness Epidemic Has Become a Global Health Issue Myopia is projected to affect half of the world’s population by 2050. A new report says it needs to be countered by classifying it as a disease and upping children’s outdoor time BY GARY STIX In 350 B.C.E. Aristotle noted that some people went about their days with what he called “short sight.” People with this condition, he found, would habitually narrow their eyelids to focus their vision—an observation widely credited as the first attempt at defining nearsightedness, or myopia. More than two millennia later, health officials are paying new attention to this old condition for a startling reason: myopia has reached epidemic levels worldwide. Myopia’s prevalence has dramatically increased in recent decades, now affecting as much as 88 percent of the population in some Asian countries. Although it seems most acute in Asian cities, myopia’s growing prevalence is by no means an exclusively regional trend. By 2050, according to one estimate, five billion people—half the world’s population—will be nearsighted. The U.S., which has been less diligent than some other countries in tracking myopia cases, saw a jump in prevalence from 25 percent of people aged 12 to 54 in the early 1970s to 42 percent in the early 2000s, according to the last major national survey of the condition. These statistics matter because myopia is a leading cause of visual impairment, and it can precipitate serious diagnoses that range from detached retinas to glaucoma. A search is now underway for tangible measures to stem this rising tide. An expert panel from the National Academies of Sciences, Engineering and Medicine (NASEM) released a report in September entitled Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease. It lays out a series of recommendations, one of which calls for the Centers for Medicare & Medicaid Services to reclassify myopia as a disease that necessitates a medical diagnosis—a step that would encourage federal and state agencies, along with professional associations, to devote resources to reversing the situation. Notably, the committee also recommended that children spend one to two hours outdoors each day. Terri L. Young, co-chair of the NASEM committee that produced the report and chair of the department of ophthalmology and visual sciences at the University of Wisconsin–Madison, talked with Scientific American about the implications of the myopia epidemic for people with myopia and policymakers. Myopia prevalence rates are at epidemic levels, especially in urban Asian communities, where in recent times upward of 80 to 90 percent of young individuals have developed myopia. There are large, government-sponsored myopia research institutes in many parts of Asia, including Taiwan, Singapore, China, Hong Kong and Japan.

Advanced Research Projects Agency for Health (ARPA-H) selected us as an awardee of the hashtag#SprintForWomensHealth to develop a high-impact and novel solution for health conditions that disproportionately affect women. 🧠 This effort explores early-stage neuroimaging advancements with transformative potential. It's led by GE HealthCare's Dr. Nastaren Abad, in collaboration with the University of Wisconsin-Madison and the Geneva Foundation/Uniformed Services University of the Health Sciences.  We're committed to developing specialized medical solutions to address women's distinct healthcare needs. Learn more: https://bit.ly/4iRdkDE

Hard to believe it, but #GSA2024 is next week! Are you interested in #healthcare topics like #digitaltwins & the built environment, age-friendly #designresearch, innovative #design & the #patientexperience, #smarttechnology & aging-in-place? Then check out this symposium that I'm honored to co-present with Maggie Calkins, Daejin Kim, Jacob Morrison, Chad R., Elisabeth Perreault, and Margi Kaminski RID, NCIDQ, ASID, IIDA, EDAC. And to make sure everything runs like clockwork, we'll be moderated by Cameron M. Contreras. We'd love to get your thoughts and feedback so stop by our symposium (details below). See you in Seattle! Designing Future Health Care Environments for an Aging Society: Transdisciplinary Perspectives Saturday, November 16, 2024 3:30 PM – 5:00 PM PST Location: Room 604 Symposium Overview: As our society grapples with demographic aging, it is imperative that we design healthcare environments that better support the well-being of older adults in the context of critical staffing shortages in the healthcare sector. Beyond aesthetics and visual appeal, thoughtful healthcare design significantly and directly impacts patient outcomes, staff well-being, and the overall quality of care. This symposium brings together four complementary presentations from the design and research fields that employ transdisciplinary perspectives to examine the issue of designing healthcare environments for an aging society.

Why should I join a clinical trial? How do I know it's safe? CEAL Scientific Pathway members, like Dr. Kanecia Zimmerman of Duke University, are answering the community's questions about clinical research in 2 YouTube video playlists: ▶️ What Scientists Want You to Know About Clinical Research ▶️ Diversity and Inclusion in Clinical Research What can you do to bring awareness to the safety of clinical research and the importance of diverse participation in clinical trials to advance health outcomes for all? Share these video shorts with your network: https://bit.ly/4eulJuc

Patient-Reported Outcome Measures may come with ambiguity, but they hold key insights in patient experience, crucial in measuring health outcomes across all healthcare domains with usefulness, accuracy, and precision. Great podcast discussing Patient-Reported Outcome Measures in the context of population health.

Meet Michael and Suzanne O'Brien from South Florida. In this series, "The Participant's Perspective on Clinical Research," Mike and Suzanne share their experience with dementia clinical research at JEM Research Institute, a Headlands Research clinical trial site. In the first video, Mike and Suzanne discuss the signs and symptoms of dementia that brought them to JEM Research Institute. #HeadlandsResearch #ClinicalTrials #ALZresearch #ClinicalTrialSites https://lnkd.in/ey94nvrt